Literature DB >> 14512272

Regulation of hepatic glucose metabolism by leptin in pig and rat primary hepatocyte cultures.

Priya Raman1, Shawn S Donkin, Michael E Spurlock.   

Abstract

Direct effects of leptin on gluconeogenesis in rat hepatocytes are equivocal, and model systems from other species have not been extensively explored in assessing the regulation of glucose metabolism by leptin. Therefore, the goal of the present study was to compare the effects of leptin on gluconeogenesis in pig and rat hepatocyte cultures as well as to investigate an underlying mechanism of action at the level of phosphoenolpyruvate carboxykinase (PEPCK). In rat hepatocytes, leptin exposure (3 h, 50 and 100 nM) attenuated glucagon-stimulated hepatic gluconeogenesis by 35 and 38% (P < 0.05), respectively. However, leptin did not produce any significant acute effect in pig hepatocytes. Leptin exposure for 24 h failed to produce any significant effect on gluconeogenesis in either rat or pig hepatocytes cultured in the presence of glucagon or dexamethasone. Mechanistically, there was a 25-35% decrease (P < 0.05) in glucagon-induced PEPCK mRNA levels in rat but not pig hepatocytes cultured with leptin. This effect on PEPCK mRNA was not due to an alteration in the relative abundance of the leptin receptor or the ability of PEPCK to respond to cAMP. The nonuniformity of the effects of leptin on gluconeogenesis in pig and rat hepatocytes indicates differences in leptin action between species. Furthermore, the unique action of leptin in porcine hepatocytes points to the utility of this model system for biomedical research and also underscores the value of comparative studies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14512272     DOI: 10.1152/ajpregu.00340.2003

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  8 in total

1.  A novel 3D liver organoid system for elucidation of hepatic glucose metabolism.

Authors:  Yanhua Lu; Guoliang Zhang; Chong Shen; Korkut Uygun; Martin L Yarmush; Qin Meng
Journal:  Biotechnol Bioeng       Date:  2011-10-19       Impact factor: 4.530

2.  Interleukin-6 mediates hepatic hypersecretion of apolipoprotein B.

Authors:  Janet D Sparks; Joanne Cianci; Jenny Jokinen; Li Sheng Chen; Charles E Sparks
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-22       Impact factor: 4.052

3.  Hormone and Drug-Mediated Modulation of Glucose Metabolism in a Microscale Model of the Human Liver.

Authors:  Matthew D Davidson; Michael Lehrer; Salman R Khetani
Journal:  Tissue Eng Part C Methods       Date:  2015-01-30       Impact factor: 3.056

4.  Immunohistochemical identification and assessment of the location of leptin, visfatin and chemerin in the liver of men with different body mass index.

Authors:  I Kasacka; Ż Piotrowska; N Domian; A Lewandowska; M Acewicz
Journal:  BMC Gastroenterol       Date:  2022-05-12       Impact factor: 2.847

5.  FTO contributes to hepatic metabolism regulation through regulation of leptin action and STAT3 signalling in liver.

Authors:  Amélie Bravard; Guillaume Vial; Marie-Agnès Chauvin; Yves Rouillé; Bernard Bailleul; Hubert Vidal; Jennifer Rieusset
Journal:  Cell Commun Signal       Date:  2014-01-10       Impact factor: 5.712

Review 6.  The role of leptin in glucose homeostasis.

Authors:  Heather C Denroche; Frank K Huynh; Timothy J Kieffer
Journal:  J Diabetes Investig       Date:  2012-03-28       Impact factor: 4.232

7.  The effect of cumulative endurance exercise on leptin and adiponectin and their role as markers to monitor training load.

Authors:  S C Voss; Z Nikolovski; P C Bourdon; M Alsayrafi; Y O Schumacher
Journal:  Biol Sport       Date:  2015-11-19       Impact factor: 2.806

8.  Mirtazapine may show anti-hyperglycemic effect by decreasing GLUT2 through leptin and galanin expressions in the liver of type 1 diabetic rats.

Authors:  Ezgi Bektur; Erhan Sahin; Cengiz Baycu
Journal:  Iran J Basic Med Sci       Date:  2019-06       Impact factor: 2.699

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.